Table 5

Associations between PA (in both methods of measurement) and LVEF, and PA and LV mass

Clinical cardiac parameterPA measurement methodModel
UnadjustedLimited adjustmentFull adjustment
Effect estimate95% CIP valueEffect estimate95% CIP valueEffect estimate95% CIP value
LVEFTotal MET-min/week−0.440−0.886 to 0.0060.053−0.415−0.863 to 0.0320.069−0.233−0.687 to 0.2210.312
Seven-day average acceleration−0.501−1.044 to 0.0410.070−0.514−1.079 to 0.0500.073−0.231−0.895 to 0.4330.493
LV massTotal MET-min/week1.388−0.222 to 2.9980.0910.969−0.178 to 2.1150.0971.3440.380 to 2.3070.006
Seven-day average acceleration2.329−0.153 to 4.8110.0662.587−0.767 to 4.4070.0053.4801.839 to 5.121<0.001
  • Effect estimate reflects an LVEF (in %) or LV mass (in g/m2) change per IQR of either total MET-min/week or 7-day average acceleration.

  • Effect estimate reflects an LVEF (in %) or LV mass (in g/m2) change per IQR of either total MET-min/week or 7- day average acceleration.

  • LV, left ventricular; LVEF, LV ejection fraction; MET, metabolic equivalent of task; PA, physical activity.